Pregnancy and COVID-19: The Possible Contribution of Vitamin D.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
10 Aug 2022
Historique:
received: 15 07 2022
revised: 08 08 2022
accepted: 09 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

Vitamin D deficiency has been associated with the severity of COVID-19. The role of vitamin D in pregnant women with COVID-19 has been poorly investigated to date. The aim of this study was to evaluate the influence of vitamin D in affecting some clinical features in pregnancy between SARS-CoV-2 positive and negative patients. Vitamin D pathway related polymorphisms and 25-hydroxyvitamin D levels were quantified in pregnant women followed from the first to the third trimester of pregnancy. Vitamin D deficiency was considered with values ≤ 30 ng/mL. In total, 160 women were enrolled: 23 resulted positive for at least one SARS-CoV-2 related test (molecular swab or antibody tests). Vitamin D-associated polymorphisms were able to affect vitamin D levels in SARS-CoV-2 negative and positive subjects: remarkably, all the This is the first study demonstrating a role of vitamin D in affecting the clinical characteristics of pregnant women during the COVID-19 era. Further studies in larger and different cohorts of patients are required to confirm these findings.

Sections du résumé

BACKGROUND BACKGROUND
Vitamin D deficiency has been associated with the severity of COVID-19. The role of vitamin D in pregnant women with COVID-19 has been poorly investigated to date. The aim of this study was to evaluate the influence of vitamin D in affecting some clinical features in pregnancy between SARS-CoV-2 positive and negative patients.
METHODS METHODS
Vitamin D pathway related polymorphisms and 25-hydroxyvitamin D levels were quantified in pregnant women followed from the first to the third trimester of pregnancy. Vitamin D deficiency was considered with values ≤ 30 ng/mL.
RESULTS RESULTS
In total, 160 women were enrolled: 23 resulted positive for at least one SARS-CoV-2 related test (molecular swab or antibody tests). Vitamin D-associated polymorphisms were able to affect vitamin D levels in SARS-CoV-2 negative and positive subjects: remarkably, all the
CONCLUSIONS CONCLUSIONS
This is the first study demonstrating a role of vitamin D in affecting the clinical characteristics of pregnant women during the COVID-19 era. Further studies in larger and different cohorts of patients are required to confirm these findings.

Identifiants

pubmed: 36014781
pii: nu14163275
doi: 10.3390/nu14163275
pmc: PMC9414046
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no potential conflict of interest.

Références

J Obstet Gynaecol Res. 2017 Feb;43(2):247-256
pubmed: 28150405
PLoS One. 2017 Jul 24;12(7):e0180483
pubmed: 28738090
J Med Virol. 2022 May;94(5):2167-2173
pubmed: 35060637
Virchows Arch. 2021 Oct;479(4):715-728
pubmed: 33934229
Mol Hum Reprod. 2020 Jun 1;26(6):367-373
pubmed: 32365180
Trends Immunol. 2020 Dec;41(12):1100-1115
pubmed: 33132005
Medicine (Baltimore). 2021 Jun 18;100(24):e26303
pubmed: 34128867
Am J Respir Crit Care Med. 2004 Nov 1;170(9):967-73
pubmed: 15282199
Clin Calcium. 2015 Nov;25(11):1613-8
pubmed: 26503864
Front Cell Infect Microbiol. 2020 Nov 25;10:587269
pubmed: 33324574
Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28
pubmed: 15951480
JBMR Plus. 2020 Sep 15;5(1):e10405
pubmed: 32904944
Mol Cell Biochem. 2021 Jun;476(6):2421-2427
pubmed: 33604809
J Med Virol. 2021 Sep;93(9):5285-5294
pubmed: 33990955
PLoS Pathog. 2020 Sep 18;16(9):e1008874
pubmed: 32946517
Physiol Rev. 2021 Jan 1;101(1):303-318
pubmed: 32969772
J Steroid Biochem Mol Biol. 2021 Oct;213:105964
pubmed: 34390830
Nat Commun. 2022 Jan 18;13(1):320
pubmed: 35042863
JAMA Netw Open. 2022 Jun 1;5(6):e2215787
pubmed: 35679048
J Matern Fetal Neonatal Med. 2021 Nov 23;:1-6
pubmed: 34812699
J Steroid Biochem Mol Biol. 2020 Sep;202:105719
pubmed: 32535032
Arch Gynecol Obstet. 2020 Sep;302(3):629-634
pubmed: 32572616
J Med Virol. 2021 Jan;93(1):250-256
pubmed: 32592501
Fertil Steril. 2014 Aug;102(2):460-468.e3
pubmed: 24933120
Int J Hematol. 2021 Jan;113(1):45-57
pubmed: 33161508

Auteurs

Alessandra Manca (A)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Stefano Cosma (S)

Obstetrics and Gynecology Unit 1, Department of Surgical Sciences, Sant'Anna Hospital, University of Turin, 10126 Turin, Italy.

Alice Palermiti (A)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Martina Costanzo (M)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Miriam Antonucci (M)

ASL Città di Torino, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Elisa Delia De Vivo (ED)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Alice Ianniello (A)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Fulvio Borella (F)

Obstetrics and Gynecology Unit 1, Department of Surgical Sciences, Sant'Anna Hospital, University of Turin, 10126 Turin, Italy.

Andrea Roberto Carosso (AR)

Obstetrics and Gynecology Unit 1, Department of Surgical Sciences, Sant'Anna Hospital, University of Turin, 10126 Turin, Italy.

Silvia Corcione (S)

Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza, 10126 Turin, Italy.

Francesco Giuseppe De Rosa (FG)

Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza, 10126 Turin, Italy.

Chiara Benedetto (C)

Obstetrics and Gynecology Unit 1, Department of Surgical Sciences, Sant'Anna Hospital, University of Turin, 10126 Turin, Italy.

Antonio D'Avolio (A)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Jessica Cusato (J)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH